Akèy › Anplwayè › SystImmune, Inc.
SystImmune, Inc.: Salè H-1B ak pajon
SystImmune, Inc. depoze 20 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 15. Medyèn salè yo ofri a: $114,026.
Èske SystImmune, Inc. pajone visa H-1B?
SystImmune, Inc. depoze 20 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Apr 27, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Scientist, Immuno-Oncology | 3 | $100,000 |
| Biostatistician | 2 | $117,013 |
| Clinical Data Manager | 2 | $145,494 |
| Accountant | 2 | $85,862 |
| Accounting Manager | 2 | $120,000 |
| Project & Operations Assistant | 2 | $82,000 |
| VP, Finance & Operations | 1 | $210,000 |
| Scientist, Cell Science | 1 | $90,000 |
| Chief Technology and Data Officer | 1 | $550,000 |
| Staff Accountant | 1 | $75,000 |
| Manager of Cell Therapy Development and Operations (CTDO) | 1 | — |
| Manager of Chief Technology and Data Officer (CTDO) Office | 1 | $130,000 |
| Financial Analyst | 1 | $80,746 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 1 | $210,000 |
| FY2025 | 14 | $110,000 |
| FY2026 | 5 | $97,386 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Accountants and Auditors5
- Statisticians3
- Molecular and Cellular Biologists3
- Medical Scientists, Except Epidemiologists3
- Data Scientists2
- Project Management Specialists2
- General and Operations Managers1
- Financial and Investment Analysts1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Biostatistician | $114,026–$134,026 Nivo III | Redmond, WA | Apr 27, 2026 | Oct 1, 2026 | Certifye |
| Financial Analyst | $80,746–$100,000 Nivo I | Redmond, WA | Apr 27, 2026 | Oct 1, 2026 | Certifye |
| Manager of Chief Technology and Data Officer (CTDO) Office | $130,000 Nivo III | Redmond, WA | Dec 31, 2025 | Jan 16, 2026 | Certifye |
| Manager of Cell Therapy Development and Operations (CTDO) | $130,000 Nivo III | Redmond, WA | Dec 30, 2025 | Jan 16, 2026 | Retire |
| Staff Accountant | $75,000–$95,000 Nivo I | Redmond, WA | Nov 26, 2025 | Dec 15, 2025 | Certifye |
| Clinical Data Manager | $140,000–$150,000 Nivo II | Redmond, WA | Jun 20, 2025 | Jul 14, 2025 | Certifye |
| Scientist, Immuno-Oncology | $100,000–$120,000 Nivo II | Redmond, WA | May 21, 2025 | Oct 1, 2025 | Certifye |
| Project & Operations Assistant | $82,000–$92,000 Nivo I | Redmond, WA | May 20, 2025 | Oct 1, 2025 | Certifye |
| Scientist, Immuno-Oncology | $100,000–$120,000 Nivo II | Redmond, WA | May 20, 2025 | Oct 1, 2025 | Retire |
| Accountant | $85,862–$95,862 Nivo II | Redmond, WA | May 20, 2025 | Oct 1, 2025 | Certifye |
| Accounting Manager | $120,000–$130,000 Nivo III | Redmond, WA | May 20, 2025 | Oct 1, 2025 | Certifye |
| Accountant | $85,862–$95,862 Nivo II | Redmond, WA | May 16, 2025 | Oct 1, 2025 | Retire |
| Accounting Manager | $120,000–$130,000 Nivo III | Redmond, WA | May 16, 2025 | Oct 1, 2025 | Retire |
| Scientist, Immuno-Oncology | $100,000–$120,000 Nivo II | Redmond, WA | May 16, 2025 | Oct 1, 2025 | Retire |
| Project & Operations Assistant | $82,000–$92,000 Nivo I | Redmond, WA | May 9, 2025 | Oct 1, 2025 | Certifye, apre retire |
| Chief Technology and Data Officer | $550,000–$580,000 Nivo IV | Redmond, WA | Feb 28, 2025 | Aug 30, 2025 | Certifye |
| Clinical Data Manager | $150,987–$180,987 Nivo III | Redmond, WA | Feb 19, 2025 | Mar 3, 2025 | Certifye |
| Biostatistician | $120,000 Nivo II | Redmond, WA | Mar 5, 2024 | Mar 18, 2024 | Certifye, apre retire |
| VP, Finance & Operations | $210,000 Nivo I | Redmond, WA | Jul 24, 2023 | Sep 2, 2023 | Certifye |
| Scientist, Cell Science | $90,000 Nivo II | Redmond, WA | May 11, 2022 | Oct 1, 2022 | Certifye, apre retire |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).